ARTICLE | Clinical News
FGN-1 chemopreventive agent: Began Phase I trials
February 14, 1994 8:00 AM UTC
Cell Pathways Inc., Denver Product: FGN-1 chemopreventive agent Indication: Prevention and treatment of colon polyps in familial adenomatous polyposis Status: Began Phase I trials ...